REGINfo: Sanofi-Aventis - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$Sanofi-Aventis: Click to view the issuer\'s details$

Last update : 13/03/2018 >View issuer details

2019.01.21 | 18:32 | Permanent Information Releases / General Company News

puce Sanofi UK marketing authorisation granted for Sanofi Pasteur’s Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose (TIV High Dose) - HTML (w)

2019.01.18 | 00:19 | Permanent Information Releases / General Company News

puce Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes - HTML (w)

2019.01.18 | 00:19 | Permanent Information Releases / General Company News

puce Sanofi : Le comité consultatif de la FDA se prononce sur ZynquistaTM (sotagliflozin) dans le traitement du diabète de type 1 de l'adulte - HTML (w)

2019.01.15 | 18:00 | Share History / Voting Rights and Number of Shares

puce Information concerning the total number of voting rights and shares - HTML (w)

2019.01.15 | 18:00 | Share History / Voting Rights and Number of Shares

puce Informations relatives au nombre total de droits de vote et d'actions - HTML (w)

2019.01.11 | 22:30 | Permanent Information Releases / Notification of availability

puce Sanofi: Availability of the Pre-quarterly Results Communication - HTML (w)

2019.01.11 | 22:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Mise en ligne du document «Pre-quarterly Results Communication » - HTML (w)

2019.01.09 | 23:00 | Permanent Information Releases / General Company News

puce New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder - HTML (w)

2019.01.09 | 23:00 | Permanent Information Releases / General Company News

puce Le New England Journal of Medicine publie les résultats positifs de l'essai pivot du Cablivi® (caplacizumab) dans le traitement d'un trouble rare de la coagulation sanguine - HTML (w)

2019.01.07 | 08:30 | Permanent Information Releases / General Company News

puce Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs - HTML (w)

2019.01.07 | 08:30 | Permanent Information Releases / General Company News

puce Sanofi et Regeneron restructurent leur collaboration de recherche et développement en immuno-oncologie - HTML (w)

2018.12.26 | 20:30 | Permanent Information Releases / General Company News

puce Sanofi: FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine - HTML (w)

2018.12.26 | 20:30 | Permanent Information Releases / General Company News

puce Sanofi : La FDA approuve VAXELIS(TM), le vaccin combiné hexavalent pédiatrique de Sanofi et MSD - HTML (w)

2018.12.19 | 13:00 | Permanent Information Releases / General Company News

puce Dengvaxia® vaccine approved for prevention of dengue in Europe - HTML (w)

2018.12.19 | 13:00 | Permanent Information Releases / General Company News

puce Le vaccin Dengvaxia® est approuvé en Europe pour la prévention de la dengue - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2612